Bio-ITWorld Systems Biology eNewsletter – Physiomics

R&D Services
Personalised Oncology
Resources
- All Resources
- FAQs
News
Investors
About
- Partners
- Team
- Careers
Contact

R&D Services
Personalised Oncology
Resources
- All Resources
- FAQs
News
Investors
About
- Partners
- Team
- Careers
Contact

R&D Services
Personalised Oncology
Resources
- All Resources
- FAQs
News
Investors
About
- Partners
- Team
- Careers
Contact

16 Jan

Bio-ITWorld Systems Biology eNewsletter

Progress for Physiomics.

Click here to read more

Categories

Other News
Investor News / RNS
Blog

Latest

ValiRx Agreement

15th February 2021
How modelling can maximise the efficacy of cancer immunotherapy

19th January 2021
Holding(s) in Company

18th December 2020
Partnership with Tabula Rasa HealthCare®’s DoseMeRx®

17th December 2020
Merck Contracts

17th December 2020
Physiomics announces approval of NIHR-funded PARTNER study

14th December 2020
Result of AGM

18th November 2020
Posting of Annual Report and AGM Notice

22nd October 2020
Contract awards

16th October 2020
Presentation and Q&A on Company’s Final Results for the year ended 30 June 2020

6th October 2020

Archive

Archive

Physiomics Plc

The Magdalen Centre

Oxford Science Park

1 Robert Robinson Avenue

Oxford, OX4 4GA

United Kingdom

Email: info@physiomics.co.uk

Phone: +44 (0) 1865 784980

Quick Links

About
R&D Services
Resources
All News
Blog
Investors
Legal & Privacy Policy
Sitemap
Contact

Latest Tweets

RT @OxfordCancer: NEW STUDY: Oxford @Ludwig_Cancer researchers have looked at how different types of cancer-causing mutations 🧬 co-operate…
A new risk prediction model has been developed by @UniofOxford that can assess #cancer patients' vulnerability to… https://t.co/2VpBk8tpF7

Newsletter

Receive news and updates from Physiomics. Select your interest below:

Corporate Scientific

Copyright © Physiomics Plc 2019. Physiomics® is a registered trademark of Physiomics Plc.

})(jQuery)